Relief and Reality: Giolito Avoids Tommy John, But 2024 Season in Doubt for Red Sox Ace
- Nishadil
- October 01, 2025
- 0 Comments
- 1 minutes read
- 53 Views
- Save
- Follow Topic
Giolito's 2024 Season in Jeopardy After Elbow Diagnosis, Avoids Tommy John Surgery
Lucas Giolito's right elbow diagnosis brings mixed news: no structural UCL damage requiring Tommy John surgery, but his 2024 season with the Red Sox is now highly unlikely. He will undergo conservative treatment.
In a mix of cautious optimism and stark reality, Boston Red Sox pitcher Lucas Giolito has received news that both spares him from the dreaded Tommy John surgery and casts a long shadow over his 2024 season. After a nerve-wracking wait, MRI results have confirmed that Giolito's right elbow does not suffer from structural damage to his ulnar collateral ligament (UCL), offering a significant sigh of relief for both the player and the Red Sox organization.
Initial reports following Giolito's discomfort during his spring training debut had fueled fears of a potential season-ending UCL tear, a common and devastating injury for pitchers.
However, expert medical opinion, including a consultation with renowned orthopedic surgeon Dr. Jeffrey Dugas, has confirmed a flexor strain and a partial tear of the UCL that, crucially, does not necessitate immediate surgical intervention. This means Giolito will embark on a path of conservative treatment, focusing on rehabilitation rather than a lengthy surgical recovery.
Despite avoiding the worst-case scenario of Tommy John surgery, the prognosis for the 2024 season remains bleak.
Red Sox general manager Craig Breslow indicated that it is .
Editorial note: Nishadil may use AI assistance for news drafting and formatting. Readers can report issues from this page, and material corrections are reviewed under our editorial standards.
